Received Jun 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | — | OT |
Ultrasound findings indicate: Intussusception: Small bowel-small bowel intussusception.; This spontaneous report was received from a consumer or other non-health professional via company representative and refers to a 2-months-old male patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported. On 27-May-2025, the patient received the first dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally administered (lot # and expiration date were not reported) for prophylaxis. On 30-May-2025, he was taken to hospital for abdominal pain. Ultrasound was performed and findings indicated intussusception, small bowel-small bowel intussusception. No Ileocolic intussusception. He was released from the emergency department (ER) on 30-May-2025. At the reporting time, the outcome of the event was unknown. The causal relationship between the event Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was not provided. Additional information is not expected.
Test Date: 20250530; Test Name: Ultrasound; Result Unstructured Data: Intussusception: Small bowel small bowel intussusception. No Ileocolic intussusception.